These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 22186319

  • 1. Glycemic control, dyslipidemia and endothelial dysfunction in coexisted diabetes, hypertension and nephropathy.
    Shahid SM, Nawab SN, Shaikh R, Mahboob T.
    Pak J Pharm Sci; 2012 Jan; 25(1):123-9. PubMed ID: 22186319
    [Abstract] [Full Text] [Related]

  • 2. Relationship between serum nitric oxide and sialic acid in coexisted diabetes, hypertension and nephropathy.
    Shahid SM, Jawed M, Mahboob T.
    Pak J Pharm Sci; 2013 May; 26(3):593-7. PubMed ID: 23625435
    [Abstract] [Full Text] [Related]

  • 3. Relationship between sialic acid and metabolic variables in Indian type 2 diabetic patients.
    Nayak SB, Bhaktha G.
    Lipids Health Dis; 2005 Aug 10; 4():15. PubMed ID: 16092968
    [Abstract] [Full Text] [Related]

  • 4. Monitoring Diabetic Nephropathy by Circulating Gangliosides.
    Ene CD, Penescu M, Anghel A, Neagu M, Budu V, Nicolae I.
    J Immunoassay Immunochem; 2016 Aug 10; 37(1):68-79. PubMed ID: 26359623
    [Abstract] [Full Text] [Related]

  • 5. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA, Hassanien MA, Ibrahim EA, El-Noeman Sel-D.
    J Diabetes Complications; 2010 Aug 10; 24(5):325-33. PubMed ID: 19553142
    [Abstract] [Full Text] [Related]

  • 6. Glycemic status, lipid profile and proteinuria in diabetic nephropathy.
    Jha P, Das BK, Shrestha S, Majhi S, Chandra L, Sharma S, Baral N.
    JNMA J Nepal Med Assoc; 2010 Aug 10; 49(178):143-6. PubMed ID: 21485601
    [Abstract] [Full Text] [Related]

  • 7. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
    Crook MA, Pickup JC, Lumb PJ, Giorgino F, Webb DJ, Fuller JH, EURODIAB IDDM Complications Study Group.
    Diabetes Care; 2001 Feb 10; 24(2):316-22. PubMed ID: 11213885
    [Abstract] [Full Text] [Related]

  • 8. Triglyceride-glucose index: A surrogate marker of homeostasis model assessment of insulin resistance to predict diabetic nephropathy.
    Khan S, Qayyum S, Khan MNA.
    J Pak Med Assoc; 2024 May 10; 74(5):862-867. PubMed ID: 38783431
    [Abstract] [Full Text] [Related]

  • 9. Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy.
    Yokoyama H, Jensen JS, Jensen T, Deckert T.
    J Intern Med; 1995 May 10; 237(5):519-23. PubMed ID: 7738493
    [Abstract] [Full Text] [Related]

  • 10. Serum lipids and the progression of nephropathy in type 1 diabetes.
    Thomas MC, Rosengård-Bärlund M, Mills V, Rönnback M, Thomas S, Forsblom C, Cooper ME, Taskinen MR, Viberti G, Groop PH.
    Diabetes Care; 2006 Feb 10; 29(2):317-22. PubMed ID: 16443880
    [Abstract] [Full Text] [Related]

  • 11. Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
    Dejenie TA, Abebe EC, Mengstie MA, Seid MA, Gebeyehu NA, Adella GA, Kassie GA, Gebrekidan AY, Gesese MM, Tegegne KD, Anley DT, Feleke SF, Zemene MA, Dessie AM, Moges N, Kebede YS, Bantie B, Adugna DG.
    Front Endocrinol (Lausanne); 2023 Feb 10; 14():1124367. PubMed ID: 37082121
    [Abstract] [Full Text] [Related]

  • 12. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.
    Chen J, Gall MA, Yokoyama H, Jensen JS, Deckert M, Parving HH.
    Diabetes Care; 1996 Feb 10; 19(2):130-4. PubMed ID: 8718432
    [Abstract] [Full Text] [Related]

  • 13. Relationship between periodontal status and dyslipidemia in patients with type 2 diabetic nephropathy and chronic periodontitis: A cross-sectional study.
    Zhang D, Zhao C, Liu Z, Ding Y, Li W, Yang H, Wang Z, Li Y.
    J Periodontal Res; 2022 Oct 10; 57(5):969-976. PubMed ID: 35848007
    [Abstract] [Full Text] [Related]

  • 14. The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy.
    Lv C, Zhou YH, Wu C, Shao Y, Lu CL, Wang QY.
    Diabetes Metab Res Rev; 2015 Oct 10; 31(7):717-24. PubMed ID: 25952368
    [Abstract] [Full Text] [Related]

  • 15. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus.
    Artha IMJR, Bhargah A, Dharmawan NK, Pande UW, Triyana KA, Mahariski PA, Yuwono J, Bhargah V, Prabawa IPY, Manuaba IBAP, Rina IK.
    Vasc Health Risk Manag; 2019 Oct 10; 15():149-157. PubMed ID: 31239693
    [Abstract] [Full Text] [Related]

  • 16. Factors Associated with Poor Glycemic and Lipid Levels in Ambulatory Diabetes Mellitus Type 2 Patients in Asmara, Eritrea: A Cross-Sectional Study.
    Achila OO, Ghebretinsae M, Kidane A, Simon M, Makonen S, Rezene Y.
    J Diabetes Res; 2020 Oct 10; 2020():5901569. PubMed ID: 32090121
    [Abstract] [Full Text] [Related]

  • 17. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
    Lepore G, Bruttomesso D, Nosari I, Tiengo A, Trevisan R.
    Diabetes Nutr Metab; 2002 Aug 10; 15(4):232-9. PubMed ID: 12416660
    [Abstract] [Full Text] [Related]

  • 18. Excessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitus.
    Wei F, Sun X, Zhao Y, Zhang H, Diao Y, Liu Z.
    BMC Nephrol; 2016 Jul 07; 17(1):67. PubMed ID: 27386849
    [Abstract] [Full Text] [Related]

  • 19. The link between diabetic retinal and renal microvasculopathy is associated with dyslipidemia and upregulated circulating level of cytokines.
    Chen X, Zhang X, Gong Z, Yang Y, Zhang X, Wang Q, Wang Y, Xie R.
    Front Public Health; 2022 Jul 07; 10():1040319. PubMed ID: 36733289
    [Abstract] [Full Text] [Related]

  • 20. Glycemic control predicts diabetic extrarenal microvascular complications but not renal survival in patients with moderate to severe chronic kidney disease.
    Crook ED, Patel S.
    Ethn Dis; 2006 Jul 07; 16(4):865-71. PubMed ID: 17061739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.